Lores, Taryn
Mikocka-Walus, Antonina
Andrews, Jane M.
Evans, Subhadra
Lynch, Kate D.
Chur-Hansen, Anna
Funding for this research was provided by:
Deakin University
Deakin University
Article History
Received: 6 January 2024
Accepted: 3 March 2024
First Online: 18 April 2024
Declarations
:
: TL: declares speaker’s fees from Mindset Health. AC-H, SE, AM-W: all declare nil conflicts of interest. KL: declares speaker’s fees, advisory Board fees, and/or conference travel/registration support from: Abbvie, Bristol Myers Squibb, Chiesi, Dr Falk, Ferring, Gilead, Guidepoint, Intercept Pharmaceuticals, Janssen-Cilag, MSD, Norgine, Pfizer, Sandoz, Takeda, the RAH Research Fund. JMA: declares speaker’s fees, advisory Board fees and educational/research grants paid to her institution from: Abbott, AbbVie, Allergan, Anatara, AstraZeneca, Bayer, BMS 2020, Celegene, Celltrion, Falk, Ferring, Gilead, Hospira, Immuninc, ImmunsanT, Janssen, MSD, Nestle, Novartis, Pfizer, Sandoz, Shire, Takeda, Vifor, RAH research Fund, The Hospital Research Fund 2020–2022, The Helmsley Trust 2020–2023. TL, AC-H, SE, AM-W, LR and JMA all declare that they have no conflicts of interest or financial disclosures for this research.
: This study was approved by the Human Research Ethics Committees (HREC) of the Central Adelaide Local Health Network (CALHN; Ref#1660) and Deakin University (DUHREC Ref#2022-236).
: All participants provided written informed consent to participate in this study.